FIJYX
Price
$37.54
Change
+$0.31 (+0.83%)
Updated
Oct 7 closing price
Net Assets
1.61B
JNGLX
Price
$74.08
Change
+$0.14 (+0.19%)
Updated
Oct 7 closing price
Net Assets
4.49B
Interact to see
Advertisement

FIJYX vs JNGLX

Header iconFIJYX vs JNGLX Comparison
Open Charts FIJYX vs JNGLXBanner chart's image
Fidelity Advisor Biotechnology Z
Price$37.54
Change+$0.31 (+0.83%)
VolumeN/A
Net Assets1.61B
Janus Henderson Global Life Sciences D
Price$74.08
Change+$0.14 (+0.19%)
VolumeN/A
Net Assets4.49B
FIJYX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
FIJYX vs. JNGLX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIJYX is a Buy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.49B vs. FIJYX (1.61B). FIJYX pays higher dividends than JNGLX: FIJYX (2.43) vs JNGLX (0.33). FIJYX was incepted earlier than JNGLX: FIJYX (7 years) vs JNGLX (27 years). JNGLX (0.80) is less costly to investors than FIJYX (0.58). FIJYX is a more actively managed with annual turnover of: 73.00 vs. JNGLX (35.00). FIJYX has a lower initial minimum investment than JNGLX: FIJYX (0) vs JNGLX (2500). FIJYX annual gain was more profitable for investors over the last year : 5.53 vs. JNGLX (-5.78). FIJYX return over 5 years is better than : 9.74 vs. JNGLX (8.81).
FIJYXJNGLXFIJYX / JNGLX
Total Expense Ratio0.580.8072%
Annual Report Gross Expense Ratio0.580.8072%
Fund Existence7 years27 years-
Gain YTD24.3908.911274%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B4.49B36%
Annual Yield % from dividends2.430.33737%
Returns for 1 year5.53-5.78-96%
Returns for 3 years52.0923.94218%
Returns for 5 years9.748.81111%
Returns for 10 yearsN/A39.97-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCCX4.25N/A
N/A
AB Discovery Growth C
TOLCX16.63N/A
N/A
DWS RREEF Global Infrastructure C
FIDZX38.62N/A
N/A
Fidelity Advisor Intl Cap App Z
SEKRX23.04N/A
N/A
DWS Emerging Markets Equity R6
PISJX16.12N/A
N/A
Columbia Pyrford International Stock R